Status:
NOT_YET_RECRUITING
RISE Ileocecal Valve Functional Reconstruction
Lead Sponsor:
Army Medical University, China
Conditions:
Right-sided Colon Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The traditional surgical treatment for right-sided colon cancer involves the removal of an important structure, the ileocecal valve, which includes the ileocecal valve. This can lead to problems such ...
Eligibility Criteria
Inclusion
- Subjects aged 18-80 years;
- ASA score ≤ 3;
- Patients newly diagnosed with tumors located in the appendix, ileocecal region, ascending colon, hepatic flexure of the colon, or the right one-third of the transverse colon, or those scheduled to undergo laparoscopic radical right hemicolectomy;
- No history of other gastrointestinal diseases (except for intestinal polyps or gallstones);
- Willing to participate in the study and sign the informed consent form;
- Complete clinical data available.
Exclusion
- Presence of other malignant tumors in different organs;
- Tumor invasion into adjacent organs;
- Patients with concurrent infectious diseases or autoimmune diseases (e.g., Crohn's disease);
- Patients with congenital or acquired metabolic disorders;
- Use of antibiotics or other microbiota-altering medications within one month prior to enrollment;
- Changes in surgical plan resulting in the resection not including the ileocecal valve.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2028
Estimated Enrollment :
188 Patients enrolled
Trial Details
Trial ID
NCT07167420
Start Date
October 1 2025
End Date
October 1 2028
Last Update
September 11 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.